Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (202) 202
humans (190) 190
life sciences & biomedicine (169) 169
infectious diseases (118) 118
male (107) 107
adult (95) 95
female (90) 90
immunology (79) 79
virology (77) 77
hiv infections - drug therapy (73) 73
hiv (69) 69
hiv infections - virology (67) 67
human immunodeficiency virus--hiv (59) 59
middle aged (59) 59
microbiology (58) 58
hiv-1 (55) 55
biological and medical sciences (52) 52
hiv-1 - genetics (49) 49
medical sciences (44) 44
viral diseases (44) 44
aids (40) 40
antiviral agents (40) 40
aids/hiv (39) 39
hiv infection (39) 39
infections (39) 39
human immunodeficiency virus (38) 38
hiv infections - immunology (37) 37
hiv infections - complications (36) 36
hiv-1 - drug effects (36) 36
patients (36) 36
acquired immune deficiency syndrome--aids (35) 35
medicine (35) 35
mutation (35) 35
human viral diseases (33) 33
multidisciplinary sciences (33) 33
science & technology - other topics (33) 33
acquired immune deficiency syndrome (32) 32
hiv-1 - immunology (31) 31
antiretroviral drugs (30) 30
science (30) 30
antiretroviral therapy (29) 29
health aspects (29) 29
research (29) 29
japan (28) 28
research article (28) 28
viral diseases of the lymphoid tissue and the blood. aids (28) 28
viral load (28) 28
risk factors (27) 27
viruses (26) 26
anti-hiv agents - therapeutic use (25) 25
virus diseases (25) 25
pharmacology & pharmacy (24) 24
pharmacology. drug treatments (24) 24
antibiotics. antiinfectious agents. antiparasitic agents (23) 23
genotype (22) 22
analysis (21) 21
young adult (21) 21
aged (20) 20
fundamental and applied biological sciences. psychology (20) 20
hiv-1 - isolation & purification (20) 20
hiv-1 - physiology (20) 20
retrospective studies (20) 20
tenofovir (20) 20
antiretroviral agents (19) 19
cd4 antigen (19) 19
hiv infections - epidemiology (19) 19
hiv patients (19) 19
drug therapy (18) 18
highly active antiretroviral therapy (18) 18
t-lymphocytes, cytotoxic - immunology (18) 18
adenine - analogs & derivatives (17) 17
anti-hiv agents - adverse effects (17) 17
anti-hiv agents - pharmacology (17) 17
care and treatment (17) 17
miscellaneous (16) 16
multivariate analysis (16) 16
ctl (15) 15
diagnosis (15) 15
medical research (15) 15
prevalence (15) 15
studies (15) 15
t cells (15) 15
cohort studies (14) 14
genetic aspects (14) 14
japan - epidemiology (14) 14
cell line (13) 13
cross-sectional studies (13) 13
epidemiology (13) 13
epitopes, t-lymphocyte - immunology (13) 13
hepatitis (13) 13
immunopathology (13) 13
incidence (13) 13
abridged index medicus (12) 12
alleles (12) 12
antiretroviral therapy, highly active (12) 12
cd4 lymphocyte count (12) 12
complications and side effects (12) 12
drug resistance, viral - genetics (12) 12
drug therapy, combination (12) 12
hiv infections - genetics (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Comment on: Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study
by Gatanaga, Hiroyuki and Oka, Shinichi
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 11/2019, Volume 74, Issue 11, pp. 3402 - 3403
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Emtricitabine | HIV Infections | Tenofovir | Prospective Studies | Rilpivirine | Humans | Anti-HIV Agents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus Infection
by Hiroyuki Gatanaga and Tsunefusa Hayashida and Junko Tanuma and Shinichi Oka
Clinical infectious diseases, ISSN 1058-4838, 6/2013, Volume 56, Issue 12, pp. 1812 - 1819
HIV/AIDS | Hepatitis | Antiretrovirals | HIV | Hepatitis antigens | Vaccination | Viruses | Infections | Hepatitis B virus | Art periods | Genotypes | resistant | tenofovir disoproxil fumarate | chronic infection | lamivudine | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiviral agents | Viral hepatitis | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | Humans | Drug Resistance, Viral | Hepatitis B - virology | Male | Alanine Transaminase - blood | Antibiotic Prophylaxis | Hepatitis B - blood | Hepatitis B Surface Antigens - blood | Tenofovir | Hepatitis B - immunology | Hepatitis B Antibodies - blood | Adenine - therapeutic use | Lamivudine - therapeutic use | Adult | Female | Retrospective Studies | HIV Infections - blood | Hepatitis B Core Antigens - blood | Anti-Retroviral Agents - therapeutic use | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | HIV Infections - virology | Kaplan-Meier Estimate | Hepatitis B Surface Antigens - immunology | Hepatitis B Core Antigens - immunology | HIV Infections - drug therapy | Hepatitis B - prevention & control | Hepatitis B Antibodies - immunology | Complications and side effects | Highly active antiretroviral therapy | Patient outcomes | Drug therapy | HIV infection | Health aspects | Risk factors | Hepatitis B | Antiretroviral drugs | Antigens | Genotype & phenotype | Drug resistance | Viral infections | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
by Kulkarni, Smita and Lied, Alexandra and Kulkarni, Viraj and Rucevic, Marijana and Martin, Maureen P and Walker-Sperling, Victoria and Anderson, Stephen K and Ewy, Rodger and Singh, Sukhvinder and Nguyen, Hoang and McLaren, Paul J and Viard, Mathias and Naranbhai, Vivek and Zou, Chengcheng and Lin, Zhansong and Gatanaga, Hiroyuki and Oka, Shinichi and Takiguchi, Masafumi and Thio, Chloe L and Margolick, Joseph and Kirk, Gregory D and Goedert, James J and Hoots, W. Keith and Deeks, Steven G and Haas, David W and Michael, Nelson and Walker, Bruce and Le Gall, Sylvie and Chowdhury, Fatema Z and Yu, Xu G and Carrington, Mary
Nature immunology, ISSN 1529-2908, 07/2019, Volume 20, Issue 7, pp. 824 - 834
Life Sciences & Biomedicine | Immunology | Science & Technology | HIV-1 | Prognosis | Humans | Receptors, CCR5 - genetics | RNA, Messenger - metabolism | Viral Load | CD4-Positive T-Lymphocytes - immunology | Genetic Variation | Receptors, CCR5 - metabolism | Cell Membrane - metabolism | 3' Untranslated Regions | CD4-Positive T-Lymphocytes - virology | Genes, Reporter | HIV Infections - genetics | HIV Infections - virology | RNA, Messenger - genetics | CD4-Positive T-Lymphocytes - metabolism | Gene Expression Regulation | Population Groups - genetics | Genotype | RNA, Long Noncoding - genetics | RNA Stability | Linkage Disequilibrium | Alleles | Biomarkers | Polymorphism, Single Nucleotide | HIV Infections - metabolism | RNA, Antisense - genetics | Medical research | Genes | Genomics | Development and progression | Antisense RNA | Genomes | Genetic transcription | T cells | HIV (Viruses) | Genetic polymorphisms | Infection | Messenger RNA | Medicine, Experimental | Genetic research | Genetic aspects | Health aspects | HIV infection | Protein binding | Genome-wide association studies | Care and treatment | Genetic variation | Analysis | Research | Single nucleotide polymorphisms | CCR5 protein | Viruses | Infections | mRNA | Lymphocytes T | Gene expression | Ribonucleic acid--RNA | CD4 antigen | RNA-binding protein | Lymphocytes | Human immunodeficiency virus--HIV | Activating transcription factor 1 | Binding sites | Genetic variance | 3' Untranslated regions | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals
by Toyoda, Mako and Kamori, Doreen and Tan, Toong Seng and Goebuchi, Kageaki and Ohashi, Jun and Carlson, Jonathan and Kawana-Tachikawa, Ai and Gatanaga, Hiroyuki and Oka, Shinichi and Pizzato, Massimo and Ueno, Takamasa
Scientific reports, ISSN 2045-2322, 11/2020, Volume 10, Issue 1, pp. 19416 - 19416
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Plasma | CCR5 protein | Nef protein | Viremia | Lymphocytes | Infectivity | Human immunodeficiency virus--HIV | Histocompatibility antigen HLA | Mutation | Immunity (cell-mediated) | CXCR4 protein | CD4 antigen | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Antiretroviral Therapy Containing HIV Protease Inhibitors Enhances Fracture Risk by Impairing Osteoblast Differentiation and Bone Quality
by Hirakawa, Hiroyuki and Gatanaga, Hiroyuki and Ochi, Hiroki and Fukuda, Toru and Sunamura, Satoko and Oka, Shinichi and Takeda, Shu and Sato, Shingo
The Journal of infectious diseases, ISSN 0022-1899, 06/2017, Volume 215, Issue 12, pp. 1893 - 1897
HIV | bone quality | integrase strand transfer inhibitor (INSTI) | osteoblast differentiation | protease inhibitor (PI) | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Lysine - analogs & derivatives | HIV-1 - drug effects | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | Biomarkers - blood | Arginine - analogs & derivatives | Osteocalcin - blood | Bone Density - drug effects | Animals | Arginine - blood | Protease Inhibitors - adverse effects | Female | Integrase Inhibitors | Mice | Retrospective Studies | Reverse Transcriptase Inhibitors | Lysine - blood | Antiviral agents | Usage | Care and treatment | Fractures | Protease inhibitors | Bones | Research | HIV (Viruses) | Osteoblasts | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Incidence and risk factors for incident hepatitis C infection among men who have sex with men with HIV-1 infection in a large urban HIV clinic in Tokyo
by Nishijima, Takeshi and Shimbo, Takuro and Komatsu, Hirokazu and Hamada, Yohei and Gatanaga, Hiroyuki and Oka, Shinichi
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 2014, Volume 65, Issue 2, pp. 213 - 217
Illicit drug use | Incident HCV infection | Injection drug use | Asia | Tokyo | Men who have sex with men | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Homosexuality, Male | Hepatitis C - epidemiology | Humans | Risk Factors | Tokyo - epidemiology | HIV Infections - complications | Adult | Male | Urban Population | Substance-Related Disorders - complications | Incidence | Hepatitis | Injections | Human immunodeficiency virus--HIV | Men | Sexual behavior | Drug use | Risk factors | Index Medicus | AIDS/HIV | Acquired immune deficiency syndrome
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection
by Ondondo, Beatrice and Murakoshi, Hayato and Clutton, Genevieve and Abdul-Jawad, Sultan and Wee, Edmund G-T and Gatanaga, Hiroyuki and Oka, Shinichi and McMichael, Andrew J and Takiguchi, Masafumi and Korber, Bette and Hanke, Tomáš
Molecular therapy, ISSN 1525-0016, 04/2016, Volume 24, Issue 4, pp. 832 - 842
Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Adenoviruses, Simian - immunology | Humans | AIDS Vaccines - immunology | CD4 Lymphocyte Count | Vaccinia virus - immunology | Viral Load | HIV Infections - immunology | Animals | HIV-1 - physiology | HIV Infections - therapy | Mice | HeLa Cells | AIDS Vaccines - administration & dosage | CD8-Positive T-Lymphocytes - immunology | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text High-Dose Oral Amoxicillin Plus Probenecid Is Highly Effective for Syphilis in Patients With HIV Infection
by Ryutaro Tanizaki and Takeshi Nishijima and Takahiro Aoki and Katsuji Teruya and Yoshimi Kikuchi and Shinichi Oka and Hiroyuki Gatanaga
Clinical infectious diseases, ISSN 1058-4838, 7/2015, Volume 61, Issue 2, pp. 177 - 183
ARTICLES AND COMMENTARIES | amoxicillin | treatment | syphilis | HIV | MSM | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Syphilis - immunology | Administration, Oral | Humans | Risk Factors | Probenecid - administration & dosage | Male | Syphilis - prevention & control | Syphilis Serodiagnosis | Treatment Outcome | CD4 Lymphocyte Count | Young Adult | Probenecid - adverse effects | Syphilis - diagnosis | Amoxicillin - therapeutic use | HIV Infections - complications | Syphilis - drug therapy | Adult | Amoxicillin - adverse effects | Amoxicillin - administration & dosage | Retrospective Studies | Syphilis - complications | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage | Probenecid - therapeutic use | Dose-response relationship (Biochemistry) | Care and treatment | Syphilis | Amoxicillin | HIV patients | Dosage and administration | Health aspects | Risk factors | Probenecid | Confidence intervals | Antibiotics | Drug dosages | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Brief Report: High Peak Level of Plasma Raltegravir Concentration in Patients With ABCB1 and ABCG2 Genetic Variants
by Tsuchiya, Kiyoto and Hayashida, Tsunefusa and Hamada, Akinobu and Oka, Shinichi and Gatanaga, Hiroyuki
Journal of acquired immune deficiency syndromes (1999), ISSN 1525-4135, 05/2016, Volume 72, Issue 1, pp. 11 - 14
Plasma concentrations | ATP-binding cassette transporter B1 | ATP-binding cassette transporter G2 | Antiretroviral therapy | Raltegravir | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | Humans | Japan | Middle Aged | Raltegravir Potassium - therapeutic use | Male | ATP-Binding Cassette Transporters - genetics | HIV Integrase Inhibitors - therapeutic use | Polymorphism, Single Nucleotide - genetics | Raltegravir Potassium - blood | Female | HIV Infections - drug therapy | HIV Integrase Inhibitors - blood | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Neoplasm Proteins - genetics | ATP Binding Cassette Transporter, Sub-Family B - genetics | Genotype & phenotype | Plasma | ABC transporters | Biological variation | Genes | Polymorphism | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Author Correction: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
by Kulkarni, Smita and Lied, Alexandra and Kulkarni, Viraj and Rucevic, Marijana and Martin, Maureen P and Walker-Sperling, Victoria and Anderson, Stephen K
Nature immunology, ISSN 1529-2908, 11/2019, Volume 20, Issue 11, pp. 1555 - 1555
HIV (Viruses) | CCR5 protein | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text High Incidence of Renal Stones Among HIV-Infected Patients on Ritonavir-Boosted Atazanavir Than in Those Receiving Other Protease Inhibitor—Containing Antiretroviral Therapy
by Yohei Hamada and Takeshi Nishijima and Koji Watanabe and Hirokazu Komatsu and Kunihisa Tsukada and Katsuji Teruya and Hiroyuki Gatanaga and Yoshimi Kikuchi and Shinichi Oka
Clinical infectious diseases, ISSN 1058-4838, 11/2012, Volume 55, Issue 9, pp. 1262 - 1269
HIV/AIDS | Antiretrovirals | Body mass index | HIV | Protease inhibitors | Predisposing factors | AIDS | Uric acid | Hepatitis B virus | Kidney stones | Arts | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiviral agents | Infectious diseases | Urinary lithiasis | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV Protease Inhibitors - adverse effects | Kidney Calculi - chemically induced | Pyridines - administration & dosage | Ritonavir - administration & dosage | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Male | HIV Protease Inhibitors - administration & dosage | Oligopeptides - adverse effects | Incidence | Anti-HIV Agents - administration & dosage | Pyridines - adverse effects | Ritonavir - adverse effects | HIV Infections - complications | Atazanavir Sulfate | Adult | Female | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Retrospective Studies | Antiretroviral Therapy, Highly Active - methods | Cohort Studies | Complications and side effects | Demographic aspects | Distribution | Dosage and administration | Research | Drug therapy | HIV infection | Antiretroviral drugs | Human immunodeficiency virus--HIV | Multivariate analysis | Medical diagnosis | Patients | Index Medicus | All-terrain vehicles | proteinase inhibitors | Antiretroviral agents | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Impact of the Maraviroc-Resistant Mutation M434I in the C4 Region of HIV-1 gp120 on Sensitivity to Antibody-Mediated Neutralization
by Boonchawalit, Samatchaya and Harada, Shigeyoshi and Shirai, Noriko and Gatanaga, Hiroyuki and Oka, Shinichi and Matsushita, Shuzo and Yoshimura, Kazuhisa
Japanese journal of infectious diseases, ISSN 1344-6304, 2016, Volume 69, Issue 3, pp. 236 - 243
HIV-1 | enhanced neutralization | neutralizing antibody | M434I mutation | maraviroc resistant mutation | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | HIV Envelope Protein gp120 - genetics | Immunoglobulin G - isolation & purification | Immune Sera - chemistry | Antibodies, Viral - pharmacology | Antibodies, Monoclonal - biosynthesis | Cyclohexanes - pharmacology | Humans | Receptors, CCR5 - genetics | Neutralization Tests | Receptors, CCR5 - immunology | CD4-Positive T-Lymphocytes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | Immunoglobulin G - biosynthesis | Immunoglobulin G - pharmacology | HIV Envelope Protein gp120 - chemistry | CD4-Positive T-Lymphocytes - virology | Antibodies, Viral - biosynthesis | Cell Line | Gene Expression | HIV-1 - drug effects | Antibodies, Monoclonal - pharmacology | HIV Infections - virology | Antibodies, Neutralizing - pharmacology | Antibodies, Monoclonal - isolation & purification | HIV Fusion Inhibitors - pharmacology | HIV-1 - genetics | Antibodies, Viral - isolation & purification | Antibodies, Neutralizing - isolation & purification | Triazoles - pharmacology | Drug Resistance, Viral - genetics | HIV-1 - immunology | Antibodies, Neutralizing - biosynthesis | Mutation | CD4-Positive T-Lymphocytes - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights